See how top analysts and institutions rate CNC — including buy, hold, and sell recommendations.
| Rating Source | Action | Rating | Target Price | Updated |
|---|---|---|---|---|
| Goldman | Initiated | Sell | $33 | 2025-10-14 |
| Cantor Fitzgerald | Downgrade | Overweight → Neutral | $38 | 2025-07-28 |
| Wells Fargo | Downgrade | Overweight → Equal Weight | $30 | 2025-07-23 |
| TD Cowen | Downgrade | Buy → Hold | $33 | 2025-07-21 |
| BofA Securities | Downgrade | Neutral → Underperform | $30 | 2025-07-16 |
| Morgan Stanley | Downgrade | Overweight → Equal-Weight | $33 | 2025-07-10 |
| UBS | Downgrade | Buy → Neutral | $45 | 2025-07-02 |
| JP Morgan | Downgrade | Overweight → Neutral | $48 | 2025-07-02 |
| Morgan Stanley | Resumed | Overweight | $70 | 2025-06-09 |
| Barclays | Downgrade | Overweight → Equal Weight | $65 | 2025-06-02 |
| Date | Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|---|
| November 2025 | 1 | 3 | 14 | 1 | 1 |
| October 2025 | 1 | 3 | 14 | 1 | 1 |
| September 2025 | 0 | 4 | 14 | 0 | 1 |
| August 2025 | 0 | 4 | 14 | 0 | 1 |
The majority of institutional investors have issued a "Buy" rating for CNC, and analyst sentiment aligns closely, with very few "Sell" recommendations. This suggests a broadly favorable outlook for the stock's performance.
